Who is the CEO of Citichem India Ltd?
The CEO of Citichem India Ltd is Mr. Arif Esmail Merchant. Under his leadership, the company has focused on expanding its presence in the specialty chemicals and APIs markets, catering to diverse industries.
Overview of the Company
Incorporated in 1992, Citichem India Limited specializes in buying and supplying organic and inorganic chemicals, bulk drugs, and food chemicals, catering primarily to the pharmaceutical industry. With a robust supply chain and dedicated distribution channels, the company offers specialty chemicals and intermediates essential for diverse industries, including aluminum, textiles, and food processing. Their portfolio includes high-demand products such as Caustic Soda Flakes and Hydrogen Peroxide.
Core Business and Market Position
Citichem India Limited operates three key business divisions: Specialty Chemicals, Food Chemicals, and Laboratory Chemicals, making it a versatile player in the chemical supply domain. Leveraging its strategic location and experienced management, Citichem has built strong supplier and customer relationships, positioning itself well in a competitive market.
Interested in the IPO? Learn more about the Citichem India IPO.
IPO Details | Information |
IPO Date | December 27–31, 2024 |
Issue Size | ₹12.60 Cr |
Price per Share | ₹70 |
Lot Size | 2,000 Shares |
Total Shares Offered | 18,00,000 |
Issue Type | Fixed Price |
Listing Exchange | BSE SME |
Purpose of the IPO
Event | Date |
IPO Open Date | December 27, 2024 |
IPO Close Date | December 31, 2024 |
Allotment Date | January 1, 2025 |
Refunds Initiated | January 2, 2025 |
Shares Credited | January 2, 2025 |
Listing Date | January 3, 2025 |
Online Application Process
Log in to Your Trading Account
Access your trading account via the web platform or mobile app.
Navigate to the IPO Section
Go to the IPO section to view active public issues.
Select the Citichem India IPO
Locate "Citichem India IPO" and click on the ‘Apply’ button.
Enter Application Details
Specify the number of lots (minimum lot size: 2000 shares).
Confirm the fixed price of ₹70 per share.
Provide Your UPI ID
Enter your UPI ID for payment authorization.
Ensure sufficient funds are available in your linked account.
Review and Submit
Verify all application details carefully before submission.
Approve the UPI mandate before 5 PM on December 31, 2024.
Key Financial Metrics
Recent Performance and Growth Prospects
Potential Risks of Investing in the IPO
Opportunities and Growth Potential
KPI | Value |
Market Cap | ₹47.60 Cr |
ROE | 15.42% |
ROCE | 21.47% |
Debt/Equity | 0.15 |
PAT Margin | 5.70% |
Registrar | Lead Manager |
Kfin Technologies Ltd | Horizon Management Pvt Ltd |
Address
7, Floor-1, Plot-96, Dharam Jyoti, Kazi Sayed Street, Khand Bazar, Masjid Station, Mandvi, Mumbai 400003
Contact
The Citichem India IPO presents an opportunity for investors to explore a company engaged in supplying speciality chemicals and APIs across diverse industries. With its fixed price issue and defined lot size, it may appeal to those looking to diversify their portfolios. Potential investors are encouraged to carefully assess the company's financials, growth prospects, and associated risks before deciding.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
The CEO of Citichem India Ltd is Mr. Arif Esmail Merchant. Under his leadership, the company has focused on expanding its presence in the specialty chemicals and APIs markets, catering to diverse industries.
The Citichem India IPO will open for subscription on December 27, 2024, and close on December 31, 2024. Investors can bid for shares during this period through authorized trading platforms.
Citichem India Ltd primarily supplies specialty chemicals, APIs, and food chemicals to industries like pharmaceuticals and textiles. Its scalable and diversified business model provides a stable foundation for long-term sustainability.
The Citichem India IPO is a fixed price issue with a total size of ₹12.60 crores. The issue consists entirely of a fresh issue of 18,00,000 shares.
‘Pre-apply’ allows investors to submit their IPO application in advance before the IPO bidding officially begins. This feature helps ensure timely participation in the Citichem India IPO.
You will receive confirmation of your Citichem India IPO order after successfully submitting your application and approving the UPI mandate.
The minimum lot size for the Citichem India IPO is 2000 shares, requiring a minimum investment of ₹1,40,000.
The allotment date for the Citichem India IPO is scheduled for January 1, 2025. Investors can check their allotment status on the registrar’s website.
Kfin Technologies Limited is the registrar for the Citichem India IPO, handling allotment and refund processes for the issue.
As of now, there are no publicly disclosed governance issues or red flags related to Citichem India Ltd’s leadership or board structure. Investors are advised to review the IPO prospectus for detailed governance information.
No Result Found
Disclaimer :
Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited
This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading